Case-control study finds decreased antioxidant levels in rheumatoid arthritis patients, highlighting the importance of antioxidant balance.
Background: Rheumatoid arthritis ( RA) , an autoimmune condition affecting joints, affects 1% of Iraqi patients. A study highlights the importance of antioxidant levels in treating RA, emphasizing the role of antioxidant markers in disease treatment and the need for balance in autoimmune conditions. Objectives: The presented work aimed to investigate the effect of rheumatoid arthritis on antioxidant status such as superoxide dismutase and total antioxidant capacity in sera of Iraqi women. Materials and Methods: A case-control study involving 130 female subjects with ages ranging between 35-65 years, who were divided into two groups: 70 rheumatoid arthritis patients and 60 apparently healthy individuals as a control. Serum superoxide dismutase activity levels and the total antioxidant capacity (TAC) were measured using an ELISA technique Results: The study revealed a significant decrease in the levels of superoxide dismutase (SOD) and TAC represented by Ferric Reducing Ability of Plasma (FRAP), in blood capacity, respectively, when comparing patients to a healthy control group. Receiver operating curve (ROC) analysis for SOD and FRAP, respectively, also showed high sensitivity and high specificity . Conclusion: Antioxidant levels play an important role in the pathophysiology of RA, so SOD and FRAP can be considered biomarkers for the evaluation of RA. Maintaining a balance between oxidative and antioxidant status is essential in the treatment of rheumatoid arthritis and other autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Sahib et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: